Continuous monitoring is reshaping oncology. CEO of AION Biosystems, Sam Barend, joins Dr. Sanjay Juneja, Dr. Douglas Flora, and Dr. David Penberthy to explore how long‑term physiologic tracking, AI‑driven insights, and clinically validated wearables are improving outcomes for patients at high risk of complications. The conversation highlights FDA pathways, reimbursement realities, and the promise of simpler, signal‑focused monitoring that detects patterns earlier and supports safer treatment continuity.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from AI and Healthcare
Could Sleep Affect Cancer Survival?
AI Is Changing Healthcare — But At What Cost?
What Clinical AI Is Doing Well... and Where It Still Needs Work
Why Most AI Startups Fail in Healthcare
Get summaries like this every morning.
Free AI-powered recaps of AI and Healthcare and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.